Unique Quality by Design Approach for Developing HPLC and LC-MS Method for Estimation of Process and Degradation Impurities in Pibrentasvir, Antiviral Agent for Hepatitis C

Divya Kumar Vemuri,Parameswari Akshinthala,Naresh Konduru,Leela Prasad Kowtharapu,Naresh Kumar Katari,Sreekantha Babu Jonnalagadda,Rambabu Gundla
DOI: https://doi.org/10.1021/acsomega.2c04617
IF: 4.1
2023-01-03
ACS Omega
Abstract:Pibrentasvir (PIB) was approved for treating hepatitis C patients. A specific, accurate, linear, robust, and stability-indicating method was developed and validated for determining degradation impurities present in the PIB drug substance by studying the quality by design (QbD) principles. All identified degradation impurities were separated with the stationary phase HALO C18, 150 mm × 4.6 mm, 2.7 μm. Mobile phase A contains pH 2.5 phosphate buffer and acetonitrile in the ratio of (70:30, v/v),...
chemistry, multidisciplinary
What problem does this paper attempt to address?